What the Study Found About Candida, Amyloid Beta and Brain Immunity
Scientists have discovered how a ubiquitous fungus can infiltrate the brain and produce proteins which are thought to be toxic and contribute to Alzheimer's disease.
The research team discovered that the fungus Candida albicans uses certain enzymes to breach the blood-brain barrier, cause brain cells to fight the infection, and produce amyloid-beta peptides by studying animal models.
Animal models were studied by the research team, which revealed that the fungus Candida albicans utilises particular enzymes to penetrate the blood-brain barrier and cause brain cells to both combat the infection and manufacture amyloid beta peptides.
The fungus Candida albicans can penetrate the brain and activate two distinct processes that help to eliminate it.
It is not yet clear how ubiquitous fungi may be connected to the onset of neurological disorders such as Alzheimer's disease. Studies have suggested a link between fungi and these chronic conditions, but more research is needed to understand this potential relationship better.
Although fungi are omnipresent, we are still uncertain about how they may be associated with neurological disorders such as Alzheimer's disease. Investigations have proposed a bond between fungi and these types of long-term illnesses, yet additional exploration is essential to obtain a more comprehensive comprehension of this potential link.
The scientists studied the correlation between C. albicans and Alzheimer's disease in animals used in experiments.
Albicans is a species of yeast that typically exists as a single-celled fungus within the natural microflora of the human body. These microorganisms can be found on the skin, mouth, and other areas.
Albicans is typically harmless when present in healthy amounts. However, if an overgrowth occurs, it can lead to infections that can cause serious health problems.
The research aimed to understand how the human body defends itself against the Candida albicans fungus believed to infect every person.
- Candida gains access to the mouse brain from the bloodstream, and the brain reacts by attempting to ward off the fungus.
- Albicans produce enzymes that weaken the blood-brain barrier, allowing for the penetration of the fungus into the brain.
- The brain's infection-fighting cells, known as microglia, detect the presence of the fungus C. albicans by interacting with candida lysin, a protein found in Candida, and CD11b, a protein found in microglia. This interaction causes the microglia to activate and eliminate the fungus.
- Amyloid May Be Generated From Two Sources: Microglia can detect the presence of C. albicans through two different pathways. The first is when Candida proteinases cleave amyloid precursor protein on neurons, resulting in fragments detected by toll-like receptor four on the microglia. This receptor activation triggers a response from the microglia that leads to the killing of the fungi.
How Candida Breaks Through The Blood-Brain Barrier
This further supports the notion that candidiasis may be linked to Alzheimer's disease, as it has been found to stimulate the production of amyloid beta, an agent responsible for warding off Candida and other microorganisms in the brain.
This research outlines how Candida can break down the blood-brain barrier, protecting the brain from bacterial and fungal infections like Candida.
When the protective layer of the brain, known as the blood-brain barrier, is weakened, there is an increased likelihood that Candida will spread to the brain.
This study, which used a mouse model and in vitro experiments, demonstrated that the fungus C. albicans could access the brain from the bloodstream by creating peptides that weaken the blood-brain barrier.
The peptides produced by C. albicans can activate amyloid pathways, which are linked to neuroinflammatory and neurodegenerative conditions, such as Alzheimer's and other forms of dementia.
Potential Implications For Developing New Treatment Strategies
Results indicate that infections caused by Candida albicans may hurt brain health. However, further research is needed to prove this.
Research has provided further proof of the potential link between C. albicans and Alzheimer's disease, as indicated by the evidence from the fungus fragments and other studies that have suggested the presence of C. albicans in the brain of Alzheimer's patients.
Researchers are unsure of the exact mechanisms by which the brain can rid itself of Candida. Still, they suggest strategies to enhance these pathways to combat the fungus more efficiently.
This research on a mouse model serves as a reminder that avoiding candidiasis is essential, even though findings from mouse models may not always apply to humans.
To prevent the growth of Candida, one should follow a diet with low sugar, abstain from taking too many antibiotics or medications that suppress one's immune system, such as steroids, utilise probiotics or fermented foods after taking antibiotics, and consume foods and herbs with natural antifungal elements such as coconut oil, garlic, and oregano.
Research has indicated that there may be a connection between microbes and Alzheimer's disease, but there are also many controllable risk factors that have been linked to Alzheimer's.
Sleep deprivation, diabetes, hypertension, lack of physical activity, obesity, hearing impairment, and loneliness are all outcomes of this.
To reduce their risk of dementia as they age, I advise my patients to take action to modify any controllable risk factors.
This study sheds light on how microglia — the brain's immune cells — initiate and maintain reactions to counteract the damaging effects of the fungus C. albicans.
The research conducted in mice may open the door to new treatments for cerebral fungal infections in humans, particularly those immunocompromised or hospitalised. Such infections can be severe and life-threatening in these populations.
You can connect with one of our doctors at Mobi Doctor with the click of a button and get the care you need.
